Back
X4 Pharmaceuticals, Inc. 10K Form
Sell
34
XFOR
X4 Pharmaceuticals, Inc.
Last Price:
$3.80
Seasonality Move:
14.77%
7 Day Trial
ALL ACCESS PASS
$
7
Key Filings
10K form not available
Receive XFOR News And Ratings
See the #1 stock for the next 7 days that we like better than XFOR
XFOR Financial Statistics
Sales & Book Value
| Annual Sales: | $2.6M |
|---|---|
| Cash Flow: | $-27.8M |
| Price / Cash Flow: | 0 |
| Annual Sales: | $2.45 |
| Price / Book: | 5.39 |
Profitability
| EPS (TTM): | -10.00720 |
|---|---|
| Net Income (TTM): | $-95.1M |
| Gross Margin: | $1.5M |
| Return on Equity: | -279.19% |
| Return on Assets: | -65.73% |
X4 Pharmaceuticals, Inc. Earnings Forecast
Key X4 Pharmaceuticals, Inc. Financial Ratios
-
The Gross Profit Margin over the past 10 years for XFOR is 57.25%.
-
The Selling, General & Administrative Expenses for XFOR have been equal to 2,405.87% of Gross Profit Margin.
-
The Research & Development expenses have been 3,181.35% of Revenue.
-
The Net Earning history of XFOR is -1,464.61% of Total Revenues.
-
Per Share Earnings over the last 10 years have been positive in 5 years.
X4 Pharmaceuticals, Inc. Stock Price Chart
Industry, Sector and Symbol
| Stock Exchange: | NASDAQ |
|---|---|
| Industry: | Biotechnology |
| Sector: | Health Care |
| Current Symbol: | XFOR |
| CUSIP: | 98420X |
| Website: | x4pharma.com |
Debt
| Debt-to-Equity Ratio: | 1.26 |
|---|---|
| Current Ratio: | 5.65 |
| Quick Ratio: | 5.25 |
Price-to-Earnings
| Trailing P/E Ratio: | 0 |
|---|---|
| Forward P/E Ratio: | 3.39 |
XFOR Technical Analysis vs Fundamental Analysis
Sell
34
X4 Pharmaceuticals, Inc. (XFOR)
is a Sell
Is X4 Pharmaceuticals, Inc. a Buy or a Sell?
-
X4 Pharmaceuticals, Inc. stock is rated a SellThe current X4 Pharmaceuticals, Inc. [XFOR] share price is $3.80. The Score for XFOR is 34, which is 32% below its historic median score of 50, and infers higher risk than normal.